[PDF][PDF] Profound tissue specificity in proliferation control underlies cancer drivers and aneuploidy patterns

LM Sack, T Davoli, MZ Li, Y Li, Q Xu, K Naxerova… - Cell, 2018 - cell.com
LM Sack, T Davoli, MZ Li, Y Li, Q Xu, K Naxerova, EC Wooten, RJ Bernardi, TD Martin
Cell, 2018cell.com
Genomics has provided a detailed structural description of the cancer genome. Identifying
oncogenic drivers that work primarily through dosage changes is a current challenge.
Unrestrained proliferation is a critical hallmark of cancer. We constructed modular, barcoded
libraries of human open reading frames (ORFs) and performed screens for proliferation
regulators in multiple cell types. Approximately 10% of genes regulate proliferation, with
most performing in an unexpectedly highly tissue-specific manner. Proliferation drivers in a …
Summary
Genomics has provided a detailed structural description of the cancer genome. Identifying oncogenic drivers that work primarily through dosage changes is a current challenge. Unrestrained proliferation is a critical hallmark of cancer. We constructed modular, barcoded libraries of human open reading frames (ORFs) and performed screens for proliferation regulators in multiple cell types. Approximately 10% of genes regulate proliferation, with most performing in an unexpectedly highly tissue-specific manner. Proliferation drivers in a given cell type showed specific enrichment in somatic copy number changes (SCNAs) from cognate tumors and helped predict aneuploidy patterns in those tumors, implying that tissue-type-specific genetic network architectures underlie SCNA and driver selection in different cancers. In vivo screening confirmed these results. We report a substantial contribution to the catalog of SCNA-associated cancer drivers, identifying 147 amplified and 107 deleted genes as potential drivers, and derive insights about the genetic network architecture of aneuploidy in tumors.
cell.com